Kypha
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Biosensia
Acquisition in 2018
Biosensia Ltd. is a company based in Dublin, Ireland, that specializes in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic platform designed to provide both quantitative and qualitative laboratory test results. RapiPlex consists of a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. This advancement supports near-patient care without sacrificing analytical performance. The platform is versatile, capable of analyzing various biological samples such as whole blood, plasma, serum, urine, saliva, and milk. Biosensia also focuses on applications in theranostics, veterinary testing, and food safety. The company was founded in 2000 and was previously known as NanoComms Ltd. Biosensia operates as a subsidiary of Kypha Inc. since 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.